Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C101370
http://purl.obolibrary.org/obo/NCIT_C101370
|
|---|---|
| Preferred Name | Immunomodulatory Agent CC-11006 |
| Definitions |
A proprietary, orally available, small molecule and thalidomide analog, with potential immunomodulating and antineoplastic activity. CC-11006 appears to have a similar mechanism to thalidomide and may modulate the expression of proinflammatory and regulatory cytokines.
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A proprietary, orally available, small molecule and thalidomide analog, with potential immunomodulating and antineoplastic activity. CC-11006 appears to have a similar mechanism to thalidomide and may modulate the expression of proinflammatory and regulatory cytokines. |
|---|---|
| prefLabel | Immunomodulatory Agent CC-11006
|
| label | Immunomodulatory Agent CC-11006
|
| NCI_META_CUI | CL435550
|
| PDQ_Closed_Trial_Search_ID | 730575
|
| code | C101370
|
| prefixIRI | NCIT:C101370
|
| in_subset |
See more
See less
|
| Display_Name | Immunomodulatory Agent CC-11006
|
| Preferred_Name | Immunomodulatory Agent CC-11006
|
| FDA_UNII_Code | 6DC9826KIM
|
| Contributing_Source |
CTRP
FDA
|
| Maps_To | Immunomodulatory Agent CC-11006
|
| CAS_Registry | 444287-44-9
|
| NCI_Drug_Dictionary_ID | 730575
|
| type | |
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 730575
|
| Semantic_Type | Pharmacologic Substance
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |